Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kribben A et al. - To reduce the risk of NSF, renal function must be determined before exposure to gadolinium-containing MR contrast agents. Gadolinium-based MR contrast media should be avoided in the presence of advanced renal failure with estimated glomerular filtration rate below 30 ml/min/1.73 m2, unless the diagnostic information is essential and not available with noncontrast magnetic resonance imaging techniques. The recommended dose of contrast agent should not be exceeded. In addition, a sufficient period of time for elimination of the contrast agent from the body should be allowed before readministration of the contrast agent.

Related Articles

UV-A1 Therapy for Nephrogenic Systemic Fibrosis
Archives of Dermatology, 10/21/09    Relevance Score: 84%

Nephrogenic systemic fibrosis
Current Opinion in Rheumatology, 11/04/09    Relevance Score: 80%

Large Sample of Nephrogenic Systemic Fibrosis Cases From a Single Institution
Archives of Dermatology, 10/21/09    Relevance Score: 80%

Advanced kidney disease, gadolinium and nephrogenic systemic fibrosis: the perfect storm
Current Opinion in Nephrology and Hypertension, 10/16/09    Relevance Score: 80%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address